Aura Biosciences, Inc.

US$6.56As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:AURAHealthcare
Country USA
PE (Fwd) •••
TSR 5Y CAGR (14.96%)
Div yield —
ROE (53.49%)
Biotechnology
Beta (5Y) 0.44
PE TTM —
TSR TTM 7.01%
Mkt cap US$680.3M
ROIC (32.90%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$7.62
16.18%
(40.27%)
Hold 6|3|9|2|6
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.12
0.14
0.15
0.15
16.79%
23.19%
29.30%
24.66%
Revenue$M
66.34
69.61
71.48
75.19
2.49%
9.22%
8.32%
16.57%
Peers (US$680.3M)
Cap (US$)
PE
689.7M
9.429x
681.7M
26.80x
Capital
TTM
5Y
10Y
Leveragex
1.094
(0.995)
(0.693)
EBIT/Intx
1.753
1.001
0.924
Own earn%
65.96
161.58
151.72
Sh yield%
58.29
40.20
41.69
Owners
Insiders/Inst%
13.08
71.62
Short interest%
4.51
SBC / revenue%
5.13
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
15
Op margin range%
22–31
$1 testx
—
Incr. ROIC%
12